The new Shareholder list at RLS Global AB

RLS Global AB completed a directed new share issue raising proceeds of SEK 50 million as of 25th of September. It is very encouraging that RLS has engaged national- and international institutions to establish a long-term foundation for the company, says Karin Fischer, CEO RLS Global. The new shareholder list can be found at RLS…

Read more

RLS Global completes a directed new share issue of 7,520,000 shares, raising proceeds of SEK 50 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA, THE "UNITED STATES"), AUSTRALIA, CANADA,  HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR…

Read more

RLS Global announces intention of a directed new share issue of shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA, THE "UNITED STATES"), AUSTRALIA, CANADA,  HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR…

Read more

RLS Global signs agreement with OneMed AB

OneMed is one of the Nordic Countries largest distributors within medical technology providing services, support systems and products to the healthcare sector. RLS Global AB has signed a cooperation agreement with OneMed AB who will act as a distributor for ChloraSolv to address the municipalities and county councils with whom they have agreements with for…

Read more

Settlement with Karin Bergqvist

Settlement with Karin Bergqvist

Read more

RLS Global AB (PUBL) - Annual Report 2018

RLS Global AB (PUBL) - Annual Report 2018

Read more

ChloraSolv receives CE marking and is cleared for commercial launch in EU

Gothenburg, Sweden, April 10th, 2019 – RLS Global AB announces that ChloraSolv, its wound care product targeting diabetic foot ulcers, has successfully obtained a CE marking based on confirmation from Lloyd’s Register, acting as Notified Body, and is therefore cleared in 32 European countries for commercialization.

Read more

Year-end report 2018

Intensified work with ChloraSolv.

Read more